C20ORF7 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.68287606072681E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.80119999920936E-08 |
Normal-vs-Stage2 |
1.626870E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
4.538900E-03 |
Stage1-vs-Stage2 |
9.264800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
8.437600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
9.173800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.74313946294569E-12 |
Normal-vs-AfricanAmerican |
9.955700E-02 |
Normal-vs-Asian |
6.674400E-02 |
Caucasian-vs-AfricanAmerican |
6.481000E-01 |
Caucasian-vs-Asian |
2.806600E-01 |
AfricanAmerican-vs-Asian |
1.497630E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.68060001868054E-09 |
Normal-vs-Female |
1.76829999976036E-07 |
Male-vs-Female |
3.235000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.029600E-04 |
Normal-vs-Extreme_Weight |
8.49349999998417E-07 |
Normal-vs-Obese |
1.625320E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.599000E-01 |
Normal_Weight-vs-Obese |
9.073600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.241600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.587400E-01 |
Normal-vs-Age(41-60Yrs) |
1.393840E-04 |
Normal-vs-Age(61-80Yrs) |
6.24969997975455E-09 |
Normal-vs-Age(81-100Yrs) |
3.9558000208828E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.851400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.366800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.022200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.415200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.865600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.318000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
8.782600E-01 |
Normal-vs-Grade 3 |
8.881000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.757800E-01 |
Grade 2-vs-Grade 4 |
8.782600E-01 |
Grade 3-vs-Grade 4 |
8.881000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.55549955933077E-10 |
Normal-vs-N1 |
1.054430E-02 |
N0-vs-N1 |
6.461000E-01 |
|
|